Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about IBB

Recent news which mentions IBB

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Layoffs at Bluebird Bio Highlight the Current Struggles of Biotech Picks
Tickers BIIB BLUE GILD IBB
Tags NVS MRK Market News
From InvestorPlace
The Daily Biotech Pulse: Pfizer Goes Shopping, AstraZeneca Inks Bispecific Antibody Deal, Aptinyx Faces Clinical Study Setback, Erytech Jumps On Data And More
Tickers ADVM ANGO APTX AZN
Tags Offerings Benzinga AZN
From Benzinga
The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy
Tickers BGNE BTAI CCCC CTXR
Tags MRK INCY News
From Benzinga
The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel
Tickers ACAD ARGX ATRA BMY
Tags NVS Market News ISBC
From Benzinga
7 Biotech Stocks to Buy With Key Catalysts for April
Tickers ABBV ALNY AMGN APTX
Tags PFE ABBV SPY
From InvestorPlace
The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight
Tickers ACAD AKBA AMLX AMRX
Tags AMRX SRRK LBPH
From Benzinga
Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates
Tickers ABBV AKBA ALNY AMRX
Tags News MRNS LIAN
From Benzinga
Positioning for Biotech Bounceback
Tickers BBC BBH IBB SBIO
Tags VanEck BBH SBIO
From ETF Trends
The Daily Biotech Pulse: SELLA In-licenses Oncology Asset, Merck's Pneumococcal Vaccine Review Extended, Arc Biopharma COVID Drug Flunks Mid-Stage Study
Tickers ABIO ESALY IBB IMMP
Tags ABIO Earnings General
From Benzinga
The Daily Biotech Pulse: Amylyx Announces Negative Adcom Vote, Clovis Jumps On Ovarian Cancer Data, Masimo Warns Of Q1 Shortfall
Tickers ADMP AFIB AFMD AMLX
Tags IBB Small Cap EDAP
From Benzinga
The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict
Tickers ADGI ADMP AFMD AMLX
Tags Top Stories AMLX SNY
From Benzinga
The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia
Tickers AKBA ALDX AMPE ATRS
Tags FDA NEO Biotech
From Benzinga
Make Biotech Cash Considerations With SBIO
Tickers BBC BBH IBB SBIO
Tags ETF Building Blocks Channel BBC IBB
From ETF Trends
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
Tickers ADMP AFIB AFMD AGRX
Tags LPCN Benzinga IMAB
From Benzinga
The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO
Tickers ANTX ATHA BMY CODX
Tags MEIP Benzinga PBLA
From Benzinga
The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
Tickers AHPA APLS ASND ATHA
Tags AHPA ASND Market News
From Benzinga
The Daily Biotech Pulse: Pfizer Reports Positive Ulcerative Colitis Study Data, Novavax COVID Shot Authorized For Adolescents In India, Argenx Stock Sale
Tickers APTO APTX ARGX BMY
Tags FDMT CELC Earnings
From Benzinga
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout
Tickers ADMP AGTC ANAB APTO
Tags APTO PFE Penny Stocks
From Benzinga
Here’s what it will take to make stocks a ‘great’ buying opportunity
Tickers AAPL AMC BA BABA
Tags YM00 ES00 BRK/A
From MarketWatch
The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings
Tickers APLT APTO APTX ASLN
Tags General DRIO ELDN
From Benzinga
Investors Should Take a Look at the Beaten Down Biotech ETFs
Tickers IBB XBI
Tags Biotechnology XBI IBB
From ETF Trends
The Daily Biotech Pulse: Moderna Files For 2nd COVID Booster Shot Authorization, Lexicon Secures Debt Funding, Amneal Gets Sub-License to Manufacture Generic COVID Pill
Tickers ACIU ALKS AMRX BNTX
Tags Biotech FDA ALKS
From Benzinga
The Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data
Tickers ABBV AFIB ALDX AVDL
Tags MDWD KPTI DVAX
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Apply For Authorization Of 3rd Booster Shot, Sanofi-Seagen Strike Cancer Therapy Pact, Iovance Gets Nod For Cancer Study
Tickers ADAG APLS BCLI BNTX
Tags News MRK General
From Benzinga
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
Tickers ALT ANAB ANIP ATHX
Tags Benzinga Offerings AZN
From Benzinga
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
Tickers ACIU ADAP ALDX ALEC
Tags ALKS Penny Stocks SYBX
From Benzinga
The Daily Biotech Pulse: Valneva Gains On COVID Shot Regulatory Update, Lucira Health And Clearside Jump On Earnings, BeiGene Drug Snags Approval In China
Tickers BGNE BPTH CLSD EBS
Tags BGNE Penny Stocks BPTH
From Benzinga
The Daily Biotech Pulse: Pfizer Begins Late-Stage Pediatric COVID Pill Study, Midatech And J&J Unit Expand R&D Collaboration, AbbVie-Alvotech Settle Humira Dispute
Tickers ABBV ACOR AMYT ASRT
Tags Offerings Benzinga AMYT
From Benzinga
7 Biotech Stocks With Key Catalysts in March
Tickers AKBA AMLX ARNA ASND
Tags TERN AMLX Market News
From InvestorPlace
The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout
Tickers ADMA ANIK AQST AXDX
Tags MTNB NSPR VYGR
From Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.